Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Particle therapy industry 360º synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Type trends
2.1.4 Product & services trends
2.1.5 System trends
2.1.6 Cancer type trends
Chapter 3 Particle Therapy Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing global burden of cancer
3.2.1.2 Advantages offered by particle therapy
3.2.1.3 Increasing number of particle therapy centers worldwide
3.2.2 Industry pitfalls & challenges
3.2.2.1 Infrastructural challenges in healthcare facilities
3.2.2.2 Unfavorable reimbursement policies and limited insurance coverage
3.3 Growth potential analysis
3.3.1 By type
3.3.2 By product & services
3.3.3 By system
3.3.4 By cancer type
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategy dashboard, 2022
Chapter 5 Particle Therapy Market, By Type, 2018 - 2032 (USD Million)
5.1 Key trends, by type
5.2 Proton therapy
5.3 Heavy ion therapy
Chapter 6 Particle Therapy Market, By Product & Services, 2018 - 2032 (USD Million)
6.1 Key trends, by product & services
6.2 Product
6.2.1 Synchrotrons
6.2.2 Cyclotrons
6.2.3 Synchrocyclotrons
6.3 Services
Chapter 7 Particle Therapy Market, By System, 2018 - 2032 (USD Million)
7.1 Key trends, by system
7.2 Multi-room systems
7.3 Single-room systems
Chapter 8 Particle Therapy Market, By Cancer Type, 2018 - 2032 (USD Million)
8.1 Key trends, by cancer type
8.2 Pediatric cancer
8.3 Lung cancer
8.4 Bladder cancer
8.5 Brain & spinal cord cancer
8.6 Head & neck cancer
8.7 Breast cancer
8.8 Gastrointestinal cancer
8.9 Other cancers
Chapter 9 Particle Therapy Market, By Region, 2018 - 2032 (USD Million)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 Rest of Middle East & Africa
Chapter 10 Company Profiles
10.1 Danfysik A/S
10.2 Hitachi, Ltd.
10.3 IBA
10.4 Mevion Medical Systems
10.5 Optivus Proton Therapy, Inc.
10.6 ProTom International
10.7 Provision Healthcare
10.8 Sumitomo Heavy Industries, Ltd.
10.9 Siemens Healthcare GmbH
10.10 Advanced Oncotherapy Plc.
